BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 32536031)

  • 1. Impact of cardiovascular events on mortality and progression of renal dysfunction in a Queensland CKD cohort.
    Jeyaruban A; Hoy W; Cameron A; Healy H; Wang Z; Zhang J; Mallett A
    Nephrology (Carlton); 2020 Nov; 25(11):839-844. PubMed ID: 32536031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spectrum (characteristics) of patients with chronic kidney disease (CKD) with increasing age in a major metropolitan renal service.
    Mahmood U; Healy HG; Kark A; Cameron A; Wang Z; Abeysekera R; Hoy WE
    BMC Nephrol; 2017 Dec; 18(1):372. PubMed ID: 29282014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic kidney disease, Queensland: Profile of patients with chronic kidney disease from regional Queensland, Australia: A registry report.
    Venuthurupalli SK; Healy H; Fassett R; Cameron A; Wang Z; Hoy WE
    Nephrology (Carlton); 2019 Dec; 24(12):1257-1264. PubMed ID: 30663166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of serum bicarbonate with risk of renal and cardiovascular outcomes in CKD: a report from the Chronic Renal Insufficiency Cohort (CRIC) study.
    Dobre M; Yang W; Chen J; Drawz P; Hamm LL; Horwitz E; Hostetter T; Jaar B; Lora CM; Nessel L; Ojo A; Scialla J; Steigerwalt S; Teal V; Wolf M; Rahman M;
    Am J Kidney Dis; 2013 Oct; 62(4):670-8. PubMed ID: 23489677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of BP with Death, Cardiovascular Events, and Progression to Chronic Dialysis in Patients with Advanced Kidney Disease.
    Palit S; Chonchol M; Cheung AK; Kaufman J; Smits G; Kendrick J
    Clin J Am Soc Nephrol; 2015 Jun; 10(6):934-40. PubMed ID: 25979975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CKD Progression and Mortality Among Men and Women: A Nationwide Study in Sweden.
    Swartling O; Rydell H; Stendahl M; Segelmark M; Trolle Lagerros Y; Evans M
    Am J Kidney Dis; 2021 Aug; 78(2):190-199.e1. PubMed ID: 33434591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endostatin in chronic kidney disease: Associations with inflammation, vascular abnormalities, cardiovascular events and survival.
    Kanbay M; Afsar B; Siriopol D; Unal HU; Karaman M; Saglam M; Gezer M; Taş A; Eyileten T; Guler AK; Aydin İ; Oguz Y; Tarim K; Covic A; Yilmaz MI
    Eur J Intern Med; 2016 Sep; 33():81-7. PubMed ID: 27394925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Relationship Between Plasma Whole Blood Viscosity and Cardiovascular Events in Patients With Chronic Kidney Disease.
    Celik T; Yilmaz MI; Balta S; Ozturk C; Unal HU; Aparci M; Karaman M; Demir M; Yildirim AO; Saglam M; Kilic S; Eyileten T; Aydin İ; Iyisoy A
    Clin Appl Thromb Hemost; 2017 Sep; 23(6):663-670. PubMed ID: 26907084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Slope of Kidney Function and Its Association with Longitudinal Mortality and Cardiovascular Disease among Individuals with CKD.
    Orlandi PF; Xie D; Yang W; Cohen JB; Deo R; Ricardo AC; Schrauben S; Wang X; Hamm LL; He J; Sondheimer JH; Kallem K; Townsend R; Raj D; Parsa A; Anderson AH; Feldman HI; ;
    J Am Soc Nephrol; 2020 Dec; 31(12):2912-2923. PubMed ID: 33023926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperuricaemia, gout and allopurinol in the CKD Queensland registry.
    Jeyaruban A; Hoy W; Cameron A; Healy H; Wang Z; Zhang J; Mallett A
    J Nephrol; 2021 Jun; 34(3):753-762. PubMed ID: 33439469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early referral strategies for management of people with markers of renal disease: a systematic review of the evidence of clinical effectiveness, cost-effectiveness and economic analysis.
    Black C; Sharma P; Scotland G; McCullough K; McGurn D; Robertson L; Fluck N; MacLeod A; McNamee P; Prescott G; Smith C
    Health Technol Assess; 2010 Apr; 14(21):1-184. PubMed ID: 20441712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative Effectiveness of Renin-Angiotensin System Inhibitors and Calcium Channel Blockers in Individuals With Advanced CKD: A Nationwide Observational Cohort Study.
    Fu EL; Clase CM; Evans M; Lindholm B; Rotmans JI; Dekker FW; van Diepen M; Carrero JJ
    Am J Kidney Dis; 2021 May; 77(5):719-729.e1. PubMed ID: 33246024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stopping Renin-Angiotensin System Inhibitors in Patients with Advanced CKD and Risk of Adverse Outcomes: A Nationwide Study.
    Fu EL; Evans M; Clase CM; Tomlinson LA; van Diepen M; Dekker FW; Carrero JJ
    J Am Soc Nephrol; 2021 Feb; 32(2):424-435. PubMed ID: 33372009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risks of Adverse Events in Advanced CKD: The Chronic Renal Insufficiency Cohort (CRIC) Study.
    Grams ME; Yang W; Rebholz CM; Wang X; Porter AC; Inker LA; Horwitz E; Sondheimer JH; Hamm LL; He J; Weir MR; Jaar BG; Shafi T; Appel LJ; Hsu CY;
    Am J Kidney Dis; 2017 Sep; 70(3):337-346. PubMed ID: 28366517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CKD.QLD: chronic kidney disease surveillance and research in Queensland, Australia.
    Venuthurupalli SK; Hoy WE; Healy HG; Salisbury A; Fassett RG;
    Nephrol Dial Transplant; 2012 Oct; 27 Suppl 3(Suppl 3):iii139-45. PubMed ID: 23115138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Referral patterns, disease progression and impact of the kidney failure risk equation (KFRE) in a Queensland Chronic Kidney Disease Registry (CKD.QLD) cohort: a study protocol.
    Mutatiri C; Ratsch A; McGrail MR; Venuthurupalli S; Kondalsamy Chennakesavan S
    BMJ Open; 2022 Feb; 12(2):e052790. PubMed ID: 35193907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Change in Kidney Function and 2-Year Mortality After Transcatheter Aortic Valve Replacement.
    Witberg G; Steinmetz T; Landes U; Pistiner Hanit R; Green H; Goldman S; Vaknin-Assa H; Codner P; Perl L; Rozen-Zvi B; Kornowski R
    JAMA Netw Open; 2021 Mar; 4(3):e213296. PubMed ID: 33769507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Warfarin, kidney dysfunction, and outcomes following acute myocardial infarction in patients with atrial fibrillation.
    Carrero JJ; Evans M; Szummer K; Spaak J; Lindhagen L; Edfors R; Stenvinkel P; Jacobson SH; Jernberg T
    JAMA; 2014 Mar; 311(9):919-28. PubMed ID: 24595776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Impact of Anaemia on Outcomes, Admissions, and Costs in Patients with Chronic Kidney Disease in Two Public Nephrology Practices in Queensland: A CKD.QLD Registry Study.
    Zhang J; Diwan V; Wang Z; Healy HG; Venuthurupalli SK; Abeysekera R; Hoy WE
    Int J Nephrol; 2023; 2023():8720293. PubMed ID: 37180548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Associations of body mass index (BMI) and BMI change with progression of chronic kidney disease in children.
    Kogon AJ; Roem J; Schneider MF; Mitsnefes MM; Zemel BS; Warady BA; Furth SL; Rodig NM
    Pediatr Nephrol; 2023 Apr; 38(4):1257-1266. PubMed ID: 36018433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.